ECCEO11-IOF » Satellite Symposia

Wednesday, 23 March
17:00 18:30	Satellite Symposium - Eli Lilly & Company Role of bone forming agents in the treatment of osteoporosis Chairs: M. Diaz Curiel & D. Agnusdei Bone quality: the case for anabolic therapy - E. Seeman Long-term side effects of osteoporosis treatments - J. Stepan Use of teriparatide in clinical practice: an update - D. Kendler	Auditorium 2
Thursday, 24 March
12:15 13:45	Lunch Symposium – Rottapharm \| Madaus Biological plausibility and clinical relevance of the of the medical management of knee osteoarthritis with crystalline glucosamine sulfate - Chairmen: E. Maheu & J.-Y. Reginster the biological plausibility of the efficacy and safety of crystalline glucosamine sulfate in osteoarthritis - L.C. Rovati the need for Slow Acting Drugs in the management of knee osteoarthritis and how crystalline glucosamine sulfate satisfies these requirements - E. Maheu the true clinical relevance of crystalline glucosamine sulfate in the treatment of knee osteoarthritis - J-Y. Reginster	Auditorium 1
12:15 13:45	Lunch Symposium - Pfizer The evolving role of SERMS: changing perspectives in the clinical management of postmenopausal osteoporosis - Chairman: S. Palacios Introductions/opening remarks - S. Palacios Are all SerMs created equal? the preclinical evidence - D. P. McDonnell From bench to bedside: the clinical profile of bazedoxifene - T. de Villiers the role of third-generation SerMs in the management of postmenopausal osteoporosis: translating data to practice - J. Calaf i Alsina panel question & answer session/Closing remarks	Auditorium 2
17:00 18:30	Satellite Symposium – Servier Healthy bone: a question of structure Chairmen: J. Cannata and R. Rizzoli Introduction - J. Cannata Improving bone health at the core - L.G. Ste-Marie Gaining bone strength with strontium ranelate - R. Rizzoli Protecting men and women from fracture - J.-Y. Reginster Repairing bones: strontium ranelate in fracture healing - J.-M. Feron Conclusion - R. Rizzoli	Auditorium 1
17:00 18:30	Satellite Symposium – MSD Emerging concepts in the management of osteoporosis: optimizing patient care Chairman: A. Diez-Perez Welcome and opening remarks - A. Diez-Perez The effective management of osteoporosis; Focus on Vitamin D - C. Roux Odanacatib: 4 years of clinical evidence in postmenopausal women - S. Papapoulos Update on osteoclast biology: identifying new targets for the treatment of osteoporosis - B. Boyce Panel discussion and Q&A	Auditorium 2
Friday, 25 March
12:15 13:45	Lunch Symposium – Amgen \| GSK Practical aspects in the treatment of osteoporosis Chairmen: N. Guanabens & S. Papapoulos Osteoporosis treatment goals - A. Diez-Perez Fracture reduction throughout the skeleton: implications for patient care - C. Roux Long-term Efficacy and Safety with Denosumab - S. Papapoulos	Auditorium 1
12:15 13:45	Lunch Symposium – Medtronic Controversies in the treatment of vertebral compression fractures Chairmen: S. Boonen & C. Bouza Impact of VCFs: Are they really devastating for the patients? - C. Cooper Current screening methods and pharmacological treatment: Are we doing the best we can? - C. Kasperk Minimally invasive surgery for VCFs: utopia or beneficial reality? - T. Blattert	Auditorium 2
Saturday, 26 March
12:15 13:45	Lunch Symposium – Danone Bone and musculoskeletal health during ageing: interplay of nutrition and exercise Chairmen: R. Rizzoli & A. Diez-Perez Introduction - R. Rizzoli Bone and muscle function decline with ageing - C. Cooper Bone and muscle metabolism in response to dietary and physical activity interventions - L. Van Loon Optimal nutritional intakes for musculoskeletal health - B. Dawson-Hughes Conclusion - A. Diez-Perez	Auditorium 2

Events plugin by anmari